Company
Amneal Pharmaceuticals, Inc. (AMRX)
Standardized SEC financial data for Amneal Pharmaceuticals, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001723128 · NASDAQ · Pharmaceutical Preparations.
Gross margin
36.9%
Operating margin
13.1%
Net margin
2.4%
Revenue growth (YoY)
8.1%
Return on equity
-101.8%
ROIC
16.3%
Free cash flow
$269.9M
Debt / equity
-36.42×
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $1.99B | $2.09B | $2.21B | $2.39B | $2.79B | $3.02B |
| Cost of revenue |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $347.1M | $256.7M | $35.2M | $99.1M | $118.4M | $312.9M |
| Inventory |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $379.0M | $241.8M | $65.1M | $345.6M | $295.1M | $340.0M |
| Capital expenditures |
Get AMRX data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/AMRX/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/AMRX/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"